ArticleBMC women's health2025
Cervical cancer screening uptake questionnaire (CCSTQ) for women: instrument development and validation.
Article in BMC women's health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07451340 (Cross-Cultural Adaptation and Psychometric Validation of the Cervical Cancer Screening Uptake Questionnaire), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Cross-Cultural Adaptation and Psychometric Validation of the Cervical Cancer Screening Uptake Questionnaire (CCSTQ) in Turkish Women
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundCervical cancer is a serious threat to women's health and is currently showing a trend of increasing incidence in young women. The screening rate for cervical cancer is lower than the WHO's target, and a scientific, comprehensive, and quantifiable evaluation is crucial to determine the factors that may affect the acceptance of cervical cancer screening. In this context, we developed a cervical cancer screening uptake questionnaire (CCSTQ), which was validated among urban and rural Chinese women.
methodsWe conducted a questionnaire development and cross-sectional validation study from April to June 2025. The CCSTQ was developed based on the Determinants of Screening UpTake model and a literature review. Content validity of the CCSTQ was established by a two-round Delphi expert consultation (n = 15). A pilot study (n = 10) was conducted to test the feasibility of the questionnaire. An online survey was administered to 560 Chinese women to assess the psychometric properties of the CCSTQ. Construct validity was evaluated by exploratory factor analysis (EFA) and confirmatory factor analysis (CFA). The Kaiser-Meyer-Olkin value and factor loadings were > 0.8 and > 0.4, respectively. Internal consistency was assessed using Cronbach's α value, and the test-retest reliability was determined using the intraclass correlation coefficient (ICC).
resultsAmong the 520 participants (mean age: 49.15 ± 18.25 years), the final 43-item CCSTQ showed high internal consistency (Cronbach's α = 0.985) and good test-retest reliability (ICC = 0.879; 95% CI = 0.787-0.932). EFA (n = 260) showed that the six-factor model explained 80.99% of the variance. CFA (n = 260) indicated good model fit (χ
conclusionsThe CCSTQ was specifically developed to assess cervical cancer screening uptake in rural and urban women through a scientifically rigorous and systematic process. The CCSTQ shows good psychometric properties and can serve as a useful empirical tool for health professionals to design personalized intervention policies and enhance health service delivery.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.